Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

SSA to add early-onset Alzheimer's disease to its Compassionate Allowances Initiative

In its effort to improve and expedite the disability determination process, the Social Security Administration has announced that it will add early-onset Alzheimer's disease to its Compassionate Allowances Initiative. The initiative identifies debilitating diseases and medical conditions that meet the SSA's disability standards for Social Security Disability Income (SSDI) or Supplemental Security Income (SSI).

12 Feb 2010

Mediterranean diet beneficial to heart health: Study

In countries bordering the Mediterranean Sea, heart disease is less common than in the United States. Researchers believe that foods common to Greece and southern Italy are a major reason for this difference.

12 Feb 2010

Social Security Administration adds early-onset Alzheimer's disease to Compassionate Allowances list: AFA lauds

The Alzheimer's Foundation of America (AFA) today applauded the Social Security Administration for including early-onset Alzheimer's disease among the medical conditions that will be given automatic approval for disability benefits, rather than have individuals go through what could be a lengthy qualification process.

12 Feb 2010

Blood test to detect elevated levels of antibodies unique to Alzheimer’s disease developed

OPKO Health, Inc. today announced the development of a simple diagnostic blood test for Alzheimer’s disease. The test, designed to detect elevated levels of antibodies unique to Alzheimer’s disease, was approximately 95% accurate in initial testing.

12 Feb 2010

Eating chocolates may lower stroke risk, but more research is needed

Eating chocolate may lower your risk of having a stroke, according to an analysis of available research that will be released today and presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010. Another study found that eating chocolate may lower the risk of death after suffering a stroke.

11 Feb 2010

Calif. budget cuts will hit adult day care centers, prison health care; Texas and Kansas weigh Medicaid cuts

Under the most recent cost-saving budget proposals, 327 adult day healthcare centers throughout California would be eliminated. Cuts could save the state $135 million in fiscal 2011, state projections show.

11 Feb 2010

Silver nanoparticles in higher-power, longer-life batteries for ICDs

Diamonds and gold may make some hearts flutter on Valentine's Day, but in a University at Buffalo laboratory, silver nanoparticles are being designed to do just the opposite.

11 Feb 2010

Intellect Neurosciences: Several significant stakeholders commit funds

Intellect Neurosciences, Inc., a biopharmaceutical company focused on development of disease-modifying therapeutic agents for Alzheimer's disease ("AD"), announced today that several of its significant shareholders (the "Interested Shareholders") have agreed in principle to provide interim funding to the Company and assist the Company in its efforts to restructure its balance sheet.

11 Feb 2010

Headache is a common and persistent symptom in people exposed to dust at World Trade Center

Workers and residents exposed to dust and fumes caused by the collapse of the World Trade Center on September 11, 2001 frequently reported headache years later, according to research released today that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010.

11 Feb 2010

Medica Foundation awards grants totaling $604,940 in second cycle of funding

The Medica Foundation wrapped up its 2009 giving with 17 program grants totaling $473,690 in its second cycle of funding in 2009. The Medica Foundation also awarded 19 General Health Improvement Grants totaling $131,250. Funding by the Medica Foundation totaled $604,940 in its second cycle; for all of 2009, its total funding was $1,353,000.

11 Feb 2010

ExonHit Therapeutics S.A. selected to participate in the European IMI consortium

ExonHit Therapeutics S.A. is pleased to announce that it has been chosen to participate in the European Innovative Medicines Initiative (IMI) consortium focused on identifying biomarkers for Alzheimer’s disease (PharmaCog).

11 Feb 2010

Migraine sufferers face increase risk of heart attack, says study

People with migraine may be at an increased risk of heart attack and other risk factors for heart disease, according to a study published in the February 10, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.

11 Feb 2010

Mental health 'bible' starts revamp with new terminology, diagnoses

The Wall Street Journal: "Mental-health experts wrestling with how to fit temper tantrums, hoarding and even Internet addiction into the current understanding of mental illness are proposing changes to the field's primary reference for diagnoses for the first time in 16 years. The draft revisions of the Diagnostic and Statistical Manual of Mental Disorders—the bible for mental health clinicians and researchers—unveiled Wednesday could have effects that ripple through mental health care."

11 Feb 2010

Feeding tube use more likely at big, for-profit hospitals

Larger, for-profit hospitals may be using too many feeding tubes on patients with advanced dementia without improving the quality of their care, a study finds, according to HealthDay News/Business Week. "Our results suggest that decisions about feeding tubes are more about which hospital you go to than a decision-making process that really elicits and supports patient choice," said the physician who led the study, which appears in today's Journal of the American Medical Association.

11 Feb 2010

Positive results from Naurex's Phase I clinical trial of GLYX-13 reported

Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel glycine site functional partial agonist (GFPA) NMDA receptor modulators, today reported positive top-line results from its Phase I clinical trial of lead compound GLYX-13.

10 Feb 2010

QR Pharma commences clinical trial of Posiphen in early stage AD patients

QR Pharma, Inc. , a developer of novel drugs to treat Alzheimer’s disease, announced today that it began a clinical trial of its lead compound, Posiphen, in early stage AD patients.

10 Feb 2010

Study calls for improved decision-making in using feeding tubes in dementia patients

Researchers from Brown University and Harvard Medical School are calling for improved decision-making in the use of feeding tubes for hospitalized nursing home residents with advanced dementia.

10 Feb 2010

Huntington's disease: Latrepirdine appears well-tolerated and beneficial

A medication previously studied in patients with Alzheimer's disease (latrepirdine) appears well tolerated and may improve thinking, learning and memory skills among individuals with Huntington's disease, according to a report in the February issue of Archives of Neurology, one of the JAMA/Archives journals.

10 Feb 2010

Neuroimaging technique could help in devising effective treatments for Alzheimer's disease

Scientists have determined that a new instrument known as PIB-PET is effective in detecting deposits of amyloid-beta protein plaques in the brains of living people, and that these deposits are predictive of who will develop Alzheimer's disease.

10 Feb 2010

Sequenom CMM licenses rights from Optherion to develop and commercialize AMD diagnostic tests

Sequenom, Inc., today announced an exclusive worldwide licensing agreement with Optherion, Inc. Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM), obtained the rights to develop and commercialize diagnostic tests to predict genetic predisposition to late stage age-related macular degeneration (AMD).

10 Feb 2010

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

SSA to add early-onset Alzheimer's disease to its Compassionate Allowances Initiative

Mediterranean diet beneficial to heart health: Study

Social Security Administration adds early-onset Alzheimer's disease to Compassionate Allowances list: AFA lauds

Blood test to detect elevated levels of antibodies unique to Alzheimer’s disease developed

Eating chocolates may lower stroke risk, but more research is needed

Calif. budget cuts will hit adult day care centers, prison health care; Texas and Kansas weigh Medicaid cuts

Silver nanoparticles in higher-power, longer-life batteries for ICDs

Intellect Neurosciences: Several significant stakeholders commit funds

Headache is a common and persistent symptom in people exposed to dust at World Trade Center

Medica Foundation awards grants totaling $604,940 in second cycle of funding

ExonHit Therapeutics S.A. selected to participate in the European IMI consortium

Migraine sufferers face increase risk of heart attack, says study

Mental health 'bible' starts revamp with new terminology, diagnoses

Feeding tube use more likely at big, for-profit hospitals

Positive results from Naurex's Phase I clinical trial of GLYX-13 reported

QR Pharma commences clinical trial of Posiphen in early stage AD patients

Study calls for improved decision-making in using feeding tubes in dementia patients

Huntington's disease: Latrepirdine appears well-tolerated and beneficial

Neuroimaging technique could help in devising effective treatments for Alzheimer's disease

Sequenom CMM licenses rights from Optherion to develop and commercialize AMD diagnostic tests

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in